BioLineRx Ltd.

ILA 1.00As of Sun 8 Nov 2026, 12:00 UTC
TASE:BLRXHealthcare
Country Israel
PE (Fwd) •••
TSR 10Y CAGR (44.75%)
Div yield —
ROE (55.27%)
Biotechnology
Beta (5Y) 0.79
PE TTM —
TSR TTM (50.00%)
Mkt cap ILS 29.87M
ROIC (26.58%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
ILA 1.00
0.04%
(22.97%)
Sell 4|2|2|0|6
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
9.32%
4.59%
(5.78%)
(1.74%)
Revenue$M
1.497
1.455
1.446
1.505
9.76%
8.47%
3.77%
3.50%
Peers (US$9.333M)
Cap (US$)
PE
10.13M
—
9.314M
2.652x
Capital
TTM
5Y
10Y
Leveragex
1.292
0.497
0.316
EBIT/Intx
4.955
0.414
0.300
Own earn%
37.53
9.96
12.67
Sh yield%
31.63
42.63
34.44
Owners
Insiders/Inst%
4.50
61.51
Short interest%
2.90
SBC / revenue%
1.41
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
6–12
$1 testx
0.0
Incr. ROIC%
37